Oncosuppressive functions of decorin
暂无分享,去创建一个
[1] R. Iozzo,et al. Soluble biglycan as a biomarker of inflammatory renal diseases. , 2014, The international journal of biochemistry & cell biology.
[2] V. Karantza,et al. Sequestosome 1/p62 facilitates HER2-induced mammary tumorigenesis through multiple signaling pathways , 2014, Oncogene.
[3] R. Iozzo,et al. Instructive roles of extracellular matrix on autophagy. , 2014, The American journal of pathology.
[4] C. Perou,et al. c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer , 2014, Oncogene.
[5] L. Zender,et al. Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles , 2014, Nature.
[6] C. López-Otín,et al. The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21 , 2014, Oncogene.
[7] R. Iozzo,et al. Endorepellin Evokes Autophagy in Endothelial Cells* , 2014, The Journal of Biological Chemistry.
[8] R. Iozzo,et al. Decorin differentially modulates the activity of insulin receptor isoform A ligands. , 2014, Matrix biology : journal of the International Society for Matrix Biology.
[9] M. Young,et al. Interclass small leucine-rich repeat proteoglycan interactions regulate collagen fibrillogenesis and corneal stromal assembly. , 2014, Matrix biology : journal of the International Society for Matrix Biology.
[10] R. Iozzo,et al. A decorin-deficient matrix affects skin chondroitin/dermatan sulfate levels and keratinocyte function. , 2014, Matrix biology : journal of the International Society for Matrix Biology.
[11] M. Young,et al. Biglycan modulates angiogenesis and bone formation during fracture healing. , 2014, Matrix biology : journal of the International Society for Matrix Biology.
[12] J. Pfeilschifter,et al. Biglycan-triggered TLR-2- and TLR-4-signaling exacerbates the pathophysiology of ischemic acute kidney injury. , 2014, Matrix biology : journal of the International Society for Matrix Biology.
[13] R. Langer,et al. Matrilin-1 Is an Inhibitor of Neovascularization* , 2014, The Journal of Biological Chemistry.
[14] I. Kovalszky,et al. Decorin deficiency promotes hepatic carcinogenesis. , 2014, Matrix biology : journal of the International Society for Matrix Biology.
[15] R. Iozzo,et al. De novo expression of circulating biglycan evokes an innate inflammatory tissue response via MyD88/TRIF pathways. , 2014, Matrix biology : journal of the International Society for Matrix Biology.
[16] F. Pontén,et al. Decreased decorin expression in the tumor microenvironment , 2014, Cancer medicine.
[17] R. Iozzo,et al. Decorin activates AMPK, an energy sensor kinase, to induce autophagy in endothelial cells. , 2014, Matrix biology : journal of the International Society for Matrix Biology.
[18] J. Hoek,et al. Decorin Induces Mitophagy in Breast Carcinoma Cells via Peroxisome Proliferator-activated Receptor γ Coactivator-1α (PGC-1α) and Mitostatin* , 2014, The Journal of Biological Chemistry.
[19] Klaus Eckert,et al. Combined Wnt/β-catenin, Met, and CXCL12/CXCR4 signals characterize basal breast cancer and predict disease outcome. , 2013, Cell reports.
[20] P. Boström,et al. Lack of Decorin Expression by Human Bladder Cancer Cells Offers New Tools in the Therapy of Urothelial Malignancies , 2013, PloS one.
[21] Clayton J. Underwood,et al. Effects of decorin proteoglycan on fibrillogenesis, ultrastructure, and mechanics of type I collagen gels. , 2013, Matrix biology : journal of the International Society for Matrix Biology.
[22] M. Duncan. Extracellular matrix transcriptome dynamics in hepatocellular carcinoma. , 2013, Matrix biology : journal of the International Society for Matrix Biology.
[23] N. Grishin,et al. EGFR-Mediated Beclin 1 Phosphorylation in Autophagy Suppression, Tumor Progression, and Tumor Chemoresistance , 2013, Cell.
[24] R. Iozzo,et al. Decorin has an appetite for endothelial cell autophagy , 2013, Autophagy.
[25] E. Brandan,et al. Role of skeletal muscle proteoglycans during myogenesis. , 2013, Matrix biology : journal of the International Society for Matrix Biology.
[26] H. Ditzel,et al. Decorin is down‐regulated in multiple myeloma and MGUS bone marrow plasma and inhibits HGF‐induced myeloma plasma cell viability and migration , 2013, European journal of haematology.
[27] R. Iozzo,et al. Decorin causes autophagy in endothelial cells via Peg3 , 2013, Proceedings of the National Academy of Sciences.
[28] Norihiro Suzuki,et al. Parkin-catalyzed Ubiquitin-Ester Transfer Is Triggered by PINK1-dependent Phosphorylation* , 2013, The Journal of Biological Chemistry.
[29] R. Iozzo,et al. Decorin induces rapid secretion of thrombospondin‐1 in basal breast carcinoma cells via inhibition of Ras homolog gene family, member A/Rho‐associated coiled‐coil containing protein kinase 1 , 2013, The FEBS journal.
[30] R. Iozzo,et al. Dichotomy of decorin activity on the insulin‐like growth factor‐I system , 2013, The FEBS journal.
[31] R. Iozzo,et al. Biological interplay between proteoglycans and their innate immune receptors in inflammation , 2013, The FEBS journal.
[32] I. Kovalszky,et al. Decorin interferes with platelet‐derived growth factor receptor signaling in experimental hepatocarcinogenesis , 2013, The FEBS journal.
[33] Gennifer E. Merrihew,et al. The PINK1–Parkin pathway promotes both mitophagy and selective respiratory chain turnover in vivo , 2013, Proceedings of the National Academy of Sciences.
[34] Jun S. Song,et al. Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF. , 2013, Cancer cell.
[35] P. Puigserver,et al. PGC1α expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. , 2013, Cancer cell.
[36] P. Keely,et al. Breast tumor and stromal cell responses to TGF-β and hypoxia in matrix deposition. , 2013, Matrix biology : journal of the International Society for Matrix Biology.
[37] G. Bhagat,et al. Akt-Mediated Regulation of Autophagy and Tumorigenesis Through Beclin 1 Phosphorylation , 2012, Science.
[38] M. Mohammadi,et al. Grb2, a Double-Edged Sword of Receptor Tyrosine Kinase Signaling , 2012, Science Signaling.
[39] R. Youle,et al. Mitochondrial quality control mediated by PINK1 and Parkin: links to parkinsonism. , 2012, Cold Spring Harbor perspectives in biology.
[40] R. Iozzo,et al. Endorepellin Affects Angiogenesis by Antagonizing Diverse Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)-evoked Signaling Pathways , 2012, The Journal of Biological Chemistry.
[41] A. Purushothaman,et al. Heparanase Enhances the Insulin Receptor Signaling Pathway to Activate Extracellular Signal-regulated Kinase in Multiple Myeloma* , 2012, The Journal of Biological Chemistry.
[42] P. Boström,et al. Localization of decorin gene expression in normal human breast tissue and in benign and malignant tumors of the human breast , 2012, Histochemistry and Cell Biology.
[43] R. Vadigepalli,et al. Decorin Protein Core Affects the Global Gene Expression Profile of the Tumor Microenvironment in a Triple-Negative Orthotopic Breast Carcinoma Xenograft Model , 2012, PloS one.
[44] W. Becker. Emerging role of DYRK family protein kinases as regulators of protein stability in cell cycle control , 2012, Cell cycle.
[45] P. Lala,et al. Mechanisms in Decorin Regulation of Vascular Endothelial Growth Factor-Induced Human Trophoblast Migration and Acquisition of Endothelial Phenotype1 , 2012, Biology of reproduction.
[46] N. Karamanos,et al. The Biology of Small Leucine-rich Proteoglycans in Bone Pathophysiology* , 2012, The Journal of Biological Chemistry.
[47] O. Grace,et al. Stromal Expression of Decorin, Semaphorin6D, SPARC, Sprouty1 and Tsukushi in Developing Prostate and Decreased Levels of Decorin in Prostate Cancer , 2012, PloS one.
[48] R. Iozzo,et al. Decorin: a guardian from the matrix. , 2012, The American journal of pathology.
[49] G. Hunnicutt,et al. Trainee Forum—Writing Winning Grants. , 2012 .
[50] T. Walther,et al. The Transcription Factor TFEB Links mTORC1 Signaling to Transcriptional Control of Lysosome Homeostasis , 2012, Science Signaling.
[51] R. Iozzo,et al. Small leucine-rich proteoglycans orchestrate receptor crosstalk during inflammation , 2012, Cell cycle.
[52] Douglas Hanahan,et al. Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment Prospects and Obstacles for Therapeutic Targeting of Function-enabling Stromal Cell Types , 2022 .
[53] N. Shinohara,et al. Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells , 2012, British Journal of Cancer.
[54] A. Ballabio,et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB , 2012, The EMBO journal.
[55] R. Iozzo,et al. The canonical Wnt pathway shapes niches supportive of hematopoietic stem/progenitor cells. , 2012, Blood.
[56] R. Iozzo,et al. Small leucine-rich proteoglycans, at the crossroad of cancer growth and inflammation. , 2012, Current opinion in genetics & development.
[57] I. Kovalszky,et al. Decorin–TGFβ Axis in Hepatic Fibrosis and Cirrhosis , 2012, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[58] R. Iozzo,et al. 3.5 Small leucine-rich proteoglycans: multifunctional signaling effectors , 2012 .
[59] H. Yao,et al. HGF-Induced PKCζ Activation Increases Functional CXCR4 Expression in Human Breast Cancer Cells , 2012, PloS one.
[60] M. Lisanti,et al. Decorin Antagonizes the Angiogenic Network , 2011, The Journal of Biological Chemistry.
[61] K. Schäfers,et al. The Role for Decorin in Delayed-Type Hypersensitivity , 2011, The Journal of Immunology.
[62] J. Pfeilschifter,et al. Signaling by the Matrix Proteoglycan Decorin Controls Inflammation and Cancer Through PDCD4 and MicroRNA-21 , 2011, Science Signaling.
[63] S. Wesselborg,et al. Role of AMPK-mTOR-Ulk1/2 in the Regulation of Autophagy: Cross Talk, Shortcuts, and Feedbacks , 2011, Molecular and Cellular Biology.
[64] J. Tovey,et al. Targeted Decorin Gene Therapy Delivered with Adeno-Associated Virus Effectively Retards Corneal Neovascularization In Vivo , 2011, PloS one.
[65] C. Stock,et al. Decorin and chondroitin‐6 sulfate inhibit B16V melanoma cell migration and invasion by cellular acidification , 2011, Journal of cellular physiology.
[66] R. Iozzo,et al. Decorin Antagonizes IGF Receptor I (IGF-IR) Function by Interfering with IGF-IR Activity and Attenuating Downstream Signaling* , 2011, The Journal of Biological Chemistry.
[67] L. Schaefer. Small leucine-rich proteoglycans in kidney disease. , 2011, Journal of the American Society of Nephrology : JASN.
[68] Andrea Ballabio,et al. TFEB Links Autophagy to Lysosomal Biogenesis , 2011, Science.
[69] G. M. Di Guglielmo,et al. Decorin is a novel VEGFR-2-binding antagonist for the human extravillous trophoblast. , 2011, Molecular endocrinology.
[70] K. Sekiguchi,et al. Endorepellin, the Angiostatic Module of Perlecan, Interacts with Both the α2β1 Integrin and Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) , 2011, The Journal of Biological Chemistry.
[71] M. Rugge,et al. Mitostatin Is Down-Regulated in Human Prostate Cancer and Suppresses the Invasive Phenotype of Prostate Cancer Cells , 2011, PloS one.
[72] Renato V Iozzo,et al. Proteoglycans in cancer biology, tumour microenvironment and angiogenesis , 2011, Journal of cellular and molecular medicine.
[73] S. Davies,et al. Decorin, erythroblastic leukaemia viral oncogene homologue B4 and signal transducer and activator of transcription 3 regulation of semaphorin 3A in central nervous system scar tissue. , 2011, Brain : a journal of neurology.
[74] N. Brüggemann,et al. Mutations in PINK1 and Parkin Impair Ubiquitination of Mitofusins in Human Fibroblasts , 2011, PloS one.
[75] Cinzia L. Marchica,et al. A role for decorin in a murine model of allergen-induced asthma. , 2011, American journal of physiology. Lung cellular and molecular physiology.
[76] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[77] I. Kovalszky,et al. Ablation of the decorin gene enhances experimental hepatic fibrosis and impairs hepatic healing in mice , 2011, Laboratory Investigation.
[78] B. Viollet,et al. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1 , 2011, Nature Cell Biology.
[79] Hong-Gang Wang,et al. The Association of AMPK with ULK1 Regulates Autophagy , 2010, PloS one.
[80] L. Scorrano,et al. Trichoplein/mitostatin regulates endoplasmic reticulum–mitochondria juxtaposition , 2010, EMBO reports.
[81] R. Iozzo,et al. Decorin Antagonizes Met Receptor Activity and Down-regulates β-Catenin and Myc Levels* , 2010, The Journal of Biological Chemistry.
[82] R. Iozzo,et al. Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine‐rich proteoglycans , 2010, The FEBS journal.
[83] Qing Jun Wang,et al. The Beclin 1-VPS34 complex--at the crossroads of autophagy and beyond. , 2010, Trends in cell biology.
[84] Angela C. Poole,et al. The Mitochondrial Fusion-Promoting Factor Mitofusin Is a Substrate of the PINK1/Parkin Pathway , 2010, PloS one.
[85] M. Komatsu,et al. Physiological significance of selective degradation of p62 by autophagy , 2010, FEBS letters.
[86] Fabienne C. Fiesel,et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1 , 2010, Nature Cell Biology.
[87] Mark D. Johnson,et al. The Imprinted Gene PEG3 Inhibits Wnt Signaling and Regulates Glioma Growth* , 2010, The Journal of Biological Chemistry.
[88] T. Kyriakides,et al. The role of thrombospondins in wound healing, ischemia, and the foreign body reaction , 2009, Journal of Cell Communication and Signaling.
[89] J. Pfeilschifter,et al. Decorin deficiency in diabetic mice: aggravation of nephropathy due to overexpression of profibrotic factors, enhanced apoptosis and mononuclear cell infiltration. , 2009, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[90] R. Iozzo,et al. Decorin is a novel antagonistic ligand of the Met receptor , 2009, The Journal of cell biology.
[91] David S. Park,et al. Loss of PINK1 Function Promotes Mitophagy through Effects on Oxidative Stress and Mitochondrial Fission* , 2009, Journal of Biological Chemistry.
[92] R. Iozzo,et al. Genetic Evidence for the Coordinated Regulation of Collagen Fibrillogenesis in the Cornea by Decorin and Biglycan* , 2009, Journal of Biological Chemistry.
[93] R. Iozzo,et al. A Central Role for Decorin during Vertebrate Convergent Extension* , 2008, Journal of Biological Chemistry.
[94] R. Iozzo,et al. Tumor microenvironment: Modulation by decorin and related molecules harboring leucine‐rich tandem motifs , 2008, International journal of cancer.
[95] L. Scorrano,et al. MITOSTATIN, a Putative Tumor Suppressor on Chromosome 12q24.1, is Down-regulated in Human Bladder and Breast Cancer , 2008, Oncogene.
[96] M. Fassan,et al. An antimetastatic role for decorin in breast cancer. , 2008, The American journal of pathology.
[97] A. Garnier,et al. Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha. , 2008, Cardiovascular research.
[98] L. Heilbronn,et al. Decorin is a secreted protein associated with obesity and type 2 diabetes , 2008, International Journal of Obesity.
[99] S. Yaccoby,et al. Role of decorin in the antimyeloma effects of osteoblasts. , 2008, Blood.
[100] Wancai Yang,et al. Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation. , 2008, Carcinogenesis.
[101] M. Söderström,et al. Differential Expression of Decorin by Human Malignant and Benign Vascular Tumors , 2008, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[102] Guido Kroemer,et al. Autophagy in the Pathogenesis of Disease , 2008, Cell.
[103] Ross Tubo,et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis , 2007, Nature.
[104] R. Hynes. Cell–matrix adhesion in vascular development , 2007, Journal of thrombosis and haemostasis : JTH.
[105] N. Davidson,et al. The forkhead box M1 transcription factor contributes to the development and growth of mouse colorectal cancer. , 2007, Gastroenterology.
[106] R. Iozzo,et al. Decorin Protein Core Inhibits in Vivo Cancer Growth and Metabolism by Hindering Epidermal Growth Factor Receptor Function and Triggering Apoptosis via Caspase-3 Activation* , 2006, Journal of Biological Chemistry.
[107] L. Soslowsky,et al. Decorin regulates assembly of collagen fibrils and acquisition of biomechanical properties during tendon development , 2006, Journal of cellular biochemistry.
[108] R. Iozzo,et al. A role for decorin in cutaneous wound healing and angiogenesis , 2006, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[109] S. Pattingre,et al. Bcl-2 inhibition of autophagy: a new route to cancer? , 2006, Cancer research.
[110] J. Folkman,et al. Antiangiogenesis in cancer therapy--endostatin and its mechanisms of action. , 2006, Experimental cell research.
[111] Carlos Cordon-Cardo,et al. Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[112] David I. Smith,et al. Biallelic methylation and silencing of paternally expressed gene 3 (PEG3) in gynecologic cancer cell lines. , 2005, Gynecologic oncology.
[113] Charles C. Reed,et al. Decorin Evokes Protracted Internalization and Degradation of the Epidermal Growth Factor Receptor via Caveolar Endocytosis* , 2005, Journal of Biological Chemistry.
[114] M. Stallcup,et al. Activation of nuclear receptor coactivator PGC-1α by arginine methylation , 2005 .
[115] R. Iozzo,et al. Decorin, a Novel Player in the Insulin-like Growth Factor System* , 2005, Journal of Biological Chemistry.
[116] R. Iozzo,et al. Decorin prevents metastatic spreading of breast cancer , 2005, Oncogene.
[117] S. Thanos,et al. Decorin Deficiency Leads to Impaired Angiogenesis in Injured Mouse Cornea , 2004, Journal of Vascular Research.
[118] S. Lipkowitz,et al. A Conserved DpYR Motif in the Juxtamembrane Domain of the Met Receptor Family Forms an Atypical c-Cbl/Cbl-b Tyrosine Kinase Binding Domain Binding Site Required for Suppression of Oncogenic Activation* , 2004, Journal of Biological Chemistry.
[119] Mogens Kruhøffer,et al. Gene Expression in the Urinary Bladder , 2004, Cancer Research.
[120] R. Iozzo,et al. Biologically Active Decorin Is a Monomer in Solution* , 2004, Journal of Biological Chemistry.
[121] R. Iozzo,et al. Decorin Binds to a Narrow Region of the Epidermal Growth Factor (EGF) Receptor, Partially Overlapping but Distinct from the EGF-binding Epitope* , 2002, The Journal of Biological Chemistry.
[122] R. Iozzo,et al. Decorin suppresses tumor cell-mediated angiogenesis , 2002, Oncogene.
[123] R. Iozzo,et al. Suppression of tumorigenicity by adenovirus-mediated gene transfer of decorin , 2002, Oncogene.
[124] T. Yamashita,et al. Peg3/Pw1 Is Involved in p53-mediated Cell Death Pathway in Brain Ischemia/Hypoxia* , 2002, The Journal of Biological Chemistry.
[125] S Kobayashi,et al. Tumour suppressor activity of human imprinted gene PEG3 in a glioma cell line , 2001, Genes to cells : devoted to molecular & cellular mechanisms.
[126] R. Iozzo,et al. An Anti-oncogenic Role for Decorin , 2000, The Journal of Biological Chemistry.
[127] L C Murphy,et al. Lumican and decorin are differentially expressed in human breast carcinoma , 2000, The Journal of pathology.
[128] M. Nugent,et al. Sustained Down-regulation of the Epidermal Growth Factor Receptor by Decorin , 2000, The Journal of Biological Chemistry.
[129] J. Schlessinger. Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.
[130] Pll Siinksen,et al. Control , 1999, Netherlands Journal of Plant Pathology.
[131] Anthony J. Guidi,et al. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[132] B. Calabretta,et al. Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[133] R. Iozzo,et al. Decorin Is a Biological Ligand for the Epidermal Growth Factor Receptor* , 1999, The Journal of Biological Chemistry.
[134] R. Iozzo,et al. Decorin Activates the Epidermal Growth Factor Receptor and Elevates Cytosolic Ca2+ in A431 Carcinoma Cells* , 1998, The Journal of Biological Chemistry.
[135] R. Iozzo,et al. Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. , 1998, The Journal of clinical investigation.
[136] Renato V. Iozzo,et al. Targeted Disruption of Decorin Leads to Abnormal Collagen Fibril Morphology and Skin Fragility , 1997, Journal of Cell Biology.
[137] M. Surani,et al. Peg3 imprinted gene on proximal chromosome 7 encodes for a zinc finger protein , 1996, Nature Genetics.
[138] T Matsumoto,et al. Bone matrix decorin binds transforming growth factor-beta and enhances its bioactivity. , 1994, The Journal of biological chemistry.
[139] C. Purdie,et al. Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. , 1994, Oncogene.
[140] R. Iozzo,et al. Neoplastic modulation of extracellular matrix: Stimulation of chondroitin sulfate proteoglycan and hyaluronic acid synthesis in co‐cultures of human colon carcinoma and smooth muscle cells , 1989, Journal of cellular biochemistry.
[141] R. Iozzo,et al. Isolation and characterization of proteoglycans synthesized by human colon and colon carcinoma. , 1982, The Journal of biological chemistry.
[142] R P Bolender,et al. Proteoglycan changes in the intercellular matrix of human colon carcinoma: an integrated biochemical and stereologic analysis. , 1982, Laboratory investigation; a journal of technical methods and pathology.
[143] A. Wells,et al. Matrikine and matricellular regulators of EGF receptor signaling on cancer cell migration and invasion , 2014, Laboratory Investigation.
[144] Mark R. Buckley,et al. Decorin expression is important for age-related changes in tendon structure and mechanical properties. , 2013, Matrix biology : journal of the International Society for Matrix Biology.
[145] S. Ryter,et al. Autophagy in human health and disease. , 2013, The New England journal of medicine.
[146] R. Iozzo,et al. Small Leucine-Rich Proteoglycans , 2011 .
[147] J. Schlessinger,et al. Signaling by Receptor Tyrosine Kinases , 1993 .